semaglutide and dementia GLP-1 Medications Associated with Reduced Likelihood of Compared to Other Diabetic Meds Associations of semaglutide with Alzheimer's
Description
It looks perfectly natural
Age also mattersas skin loses elasticity over time, capillaries become more vulnerable to rupture from injection trauma
By delivering energy beneath the surface, it stimulates collagen remodeling where laxity truly begins
In patients with overweight or obesity (mean age 50.1 years, 72.6% female), semaglutide compared with non-GLP1R agonist anti-obesity medications was associated with lower risk for incident (HR = 0.27, 95% CI = 0.200.320.600.36) and recurrent (HR = 0.44, 95% CI = 0.320.60) suicidal ideation, consistent across sex, age and ethnicity stratification
Our study demonstrates that direct cartilage protection is not only achievable but central to achieving therapeutic efficacy
doi: 10.1016/j.ajcnut.2025.04.023
